key: cord-0987350-rqxkbpgo
authors: Phetcharakupt, Varistha; Pasomsub, Ekawat; Kiertiburanakul, Sasisopin
title: Clinical manifestations of influenza and performance of rapid influenza diagnostic test: A university hospital setting
date: 2021-10-01
journal: Health Sci Rep
DOI: 10.1002/hsr2.408
sha: 15b01f5eb11f5b7cedf77a04daa4e6ad2f548dd0
doc_id: 987350
cord_uid: rqxkbpgo

BACKGROUND: Rapid influenza diagnostic test (RIDT) is a diagnostic tool that detects the influenza virus nucleoprotein antigen. The RIDT is widely used in clinical practice because it is simple and cost‐effective, and provides results within 10‐15 minutes. OBJECTIVE: We aimed at evaluating the sensitivity and specificity of the Sofia® RIDT compared with the Luminex® multiplex polymerase chain reaction (PCR). The other goal was to determine the predicting factors for diagnosing influenza among individuals with influenza‐like illness (ILI). METHOD: Patients with ILI who had the results of both tests were retrospectively reviewed. We determined the performances of the RIDT. RESULTS: A total of 473 patients were included with a median age of 58 (interquartile range 41‐74) years. Of these, 47.1% were male, and 16.2% were diagnosed with influenza by the RIDT or RT‐PCR's positive test. For influenza A, the RIDT showed a sensitivity of 76.3% (95% confidence interval [CI] 59.8‐88.6) and a specificity of 97.9% (95% CI 96.1‐99.0), whereas for influenza B, it showed a sensitivity of 47.1% (95% CI 23.0‐72.2) and a specificity of 97.1% (95% CI 95.2‐98.5). Patients with influenza were more likely to present with fever (81.8% vs 63.1%), cough (81.8% vs 66.1%), and rhinorrhea (41.6% vs 26.5%) compared to those without influenza (P < 0.05, all), and had a higher proportion of pneumonia (19.5% vs 10.6%, P = 0.029) and acute respiratory distress syndrome (5.2% vs 1.5%, P = 0.063). The predicting factors for influenza among patients presented with ILI were cough (odds ratio [OR] 2.77; 95% CI 0.21‐0.81, P = 0.010), rhinorrhea (OR 1.87; 95% CI 1.03‐3.36, P = 0.037), and higher body temperature (OR 1.64; 95% CI 1.23‐2.19, P = 0.001). CONCLUSIONS: The sensitivity of the RIDT for the diagnosis of influenza is fair in contrast to the specificity. Among patients with ILI, cough, rhinorrhea, and higher body temperature might be factors for predicting influenza.

Inclusion criteria were (a) age more than 15 years and (b) having ILI, which were fever, cough, rhinorrhea, sore throat, muscle aches, headache, and fatigue. 19 Exclusion criteria were unavailable medical data records for the review. The sample size was calculated by the formula of Z 2 α p(1-p)/d 2 with substituted specificity (p) with 0.9, Z α with 1.96, and standard deviation (d) with 0.05. The calculated sample size plus 10% dropout was 153. The specificity that is used to calculate the sample size is from the study of the RIDT in Thailand. 20 Demographic data were retrieved and reviewed, including age, gender, and underlying disease (eg, diabetes, hypertension, airway disease, cardiovascular disease, malignancy, HIV infection, immunosuppressive therapy, transplantation status, and pregnancy). Information of signs and symptoms was obtained by reviewing the medical records. In addition, the results of laboratory investigations and chest radiography were also reviewed. Data regarding the length of stay, treatment, and clinical outcomes were obtained from the hospital database. A patient diagnosed with influenza infection was defined by positive results of the RIDT or multiplex RT-PCR analysis.

Rapid influenza diagnostic test 17 : The Sofia ® influenza A+B FIA (Quidel Corporation, CA, USA) is a fluorescent immunoassay that uses advanced immunofluorescence-based lateral-flow technology to detect influenza A and influenza B viral nucleoprotein antigens using the Sofia analyzer platform, which contains a microprocessorcontrolled optics unit that scans the nitrocellulose test strip's length; therefore, the strip is exposed to UV light from the emitting diode. A positive result is determined by detecting a fluorescent signal at levels above a signal threshold set on a negative-control line. This process is controlled by a specific algorithm embedded in the Sofia analyzer. The Sofia analyzer automatically scans the test strip, analyzes the fluorescence data, and calculates and reports the result. The Sofia ® influenza A+B FIA testing was performed, followed by the manufacturer's recommendations. After the sample was prepared, it was incubated for 15 minutes before being analyzed.

Multiplex RT-PCR 21 Table 2 .

Laboratory and radiographic findings of 473 patients present with ILI are shown in Table 3 . There was no statistically significant difference in the laboratory and radiologic findings between patients with and without influenza (P > 0.05, all). However, patients with influenza were more likely to have a higher percentage of neutrophil count (76% vs 75%, P = 0.069) and hematocrit (35% vs 33%, P = 0.071).

Of all, 20.3% had at least one complication, 72.3% had clinical improvement, and overall mortality was 1.6%. Patients with influenza had a significant higher proportion of complications (28.6% vs 17.7%, P = 0.048), especially pneumonia (19.5% vs 10.6%, P = 0.029) and acute respiratory distress syndrome (5.2% vs 1.5%, P = 0.063). However, the mortality rate was not significantly different between patients with and without influenza (2.6% vs 1.5%, P = 0.682).

Patients with influenza were more likely to receive an antiviral drug (90.9% vs 4.8%, P < 0.001) and less likely to receive antibiotics (49.3% vs 81.8%, P < 0.001) ( patients with these symptoms should be considered a diagnosis of influenza, especially during seasonal influenza and in the setting of resource constraints for the laboratory diagnosis. In our study, patients with influenza had a higher proportion of complications than those without influenza, whereas the study in Singapore reported a higher complication in a non-diagnosis of the influenza group (eg, bacterial infection). 26 The most common complications in our patients were pneumonia and acute respiratory distress syndrome (ARDS). The common complication in patients with influenza reported by the studies in Japan, China, and the United States was pneumonia. 2, 25, 27 In contrast, Singapore's research said the most common complication was neurological complications such as seizures because most study populations were children. 26 Most of our patients with influenza had improved in the outcomes, and a few cases died. The mortality rate in our study is similar to that reported from the others, 0.4%-6.7%. 1, [26] [27] [28] Most of the severe cases were elderly aged and had comorbidities. 27, 28 There are some limitations of this study. First, unavailable medical records and missing data such as a history of receiving influenza vaccine are common due to the retrospective study's nature. Second, this study was conducted in a single center that might not be generalized to other populations or other settings. The low prevalence of influenza B in our study might have affected the performance of RIDT.

However, our study's benefit is evaluating the parameter associated with a diagnosis of influenza. This might help a physician decide on the diagnosis and treatment of influenza in a situation where any confirmation test could not be performed.

In conclusion, the Sofia ® influenza A+B FIA can be one of the helpful diagnostic tools in diagnosing influenza. According to high specificity in Sofia ® influenza A+B FIA, positive results in ILI patients are more likely to be true-positive results. On the other hand, we cannot exclude influenza because of Sofia ® influenza A+B FIA's negative result among patients with ILI. Thus, the RT-PCR should be used to confirm the influenza diagnosis among patients presented with ILI using the proposed clinical predicting factors where infrastructure is constrained.

of the data analysis.

All the authors affirm that this manuscript is an honest, accurate, and transparent account of the study being reported, and no important aspects of the study have been omitted.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Ethical approval for this study was obtained from the Committee on 

Influenza-associated inhospital mortality during the 2017/2018 influenza season: a retrospective multicentre cohort study in central Germany

The burden of influenza and pneumonia mortality attributable to absolute humidity among elderly people in Chongqing

Clinical manifestations and risk factors for mortality of patients with severe influenza during the 2016-2018 season

Surveillance Report of Seasonal Influenza. Department of Disease Control, Ministry of Public Health

Economic burden of influenza in Thailand: a systematic review

Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis

Center of Disases Control and Prevention. Overview of Influenza Testing Methods

Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection

Multiplexed reverse transcriptase PCR assay for identification of viral respiratory pathogens at the point of care

Comparisons of clinical characteristics between adult patients with 2009 H1N1 influenza and those with seasonal influenza during the 2009 epidemic in Thailand

Evaluation of 11 commercially available rapid influenza diagnostic tests-United States

Diagnostic performance of the Sofia ® influenza A+B fluorescent immunoassay in adult outpatients in northern Taiwan

Rapid point-of-care influenza testing for patients in German emergency rooms -a cost-benefit analysis

Evaluation of Sofia fluorescent immunoassay analyzer for influenza A/B virus

Evaluation of the Sofia Influenza A + B fluorescent immunoassay for the rapid diagnosis of influenza A and B

Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial

Detection of influenza a and B viruses with the Sofia analyzer: a novel, rapid immunofluorescence-based in vitro diagnostic device

Performance of rapid Sofia influenza A+B test compared to Luminex x-TAG respiratory viral panel assay in the diagnosis of influenza a, B, and subtype H3

Considerations for distinguishing influenza-like illness from inhalational anthrax

Field performance and new uses of rapid influenza testing in Thailand

Comparison of Luminex NxTAG respiratory pathogen panel and xTAG respiratory viral panel fast version 2 for the detection of respiratory viruses

Accuracy of rapid influenza diagnostic tests: a meta-analysis

Performance of the Quidel Sofia rapid influenza diagnostic test during the 2012-2013 and 2013-2014 influenza seasons. Influenza Other Respir Viruses

Low sensitivity of rapid diagnostic test for influenza

Clinical manifestations of adult patients requiring influenza-associated hospitalization: a prospective multicenter cohort study in Japan via internet surveillance

The burden and clinical manifestation of hospitalized influenza among different pediatric age-groups in the tropics. Influenza Other Respir Viruses

The burden of influenza: a complex problem

Burden of influenza in Romania. A retrospective analysis of 2014/15 -2018/19 seasons in Romania

Clinical manifestations of influenza and performance of rapid influenza diagnostic test: A university hospital setting

The author would like to acknowledge and thank all the patients participating in the study and the hospital staff who cared for the patients.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The authors declare that they have no competing interests. All authors had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy